Ching-Chieh Yang1,2, Bor-Hwang Kang3,4,5, Wen-Shan Liu6, Chun-Hao Yin7, Ching-Chih Lee8,9,10. 1. Department of Radiation Oncology, Chi-Mei Medical Center, Tainan, Taiwan. 2. Department of Pharmacy, Chia-Nan University of Pharmacy and Science, Tainan, Taiwan. 3. Department of Otolaryngology, Head and Neck Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan. 4. School of Medicine, National Defense Medical Center, Taipei, Taiwan. 5. Department of Pharmacy, Tajen University, Pingtung, Taiwan. 6. Department of Radiaton Oncology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan. 7. Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan. 8. Department of Otolaryngology, Head and Neck Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan. hematcd2@hotmail.com. 9. School of Medicine, National Defense Medical Center, Taipei, Taiwan. hematcd2@hotmail.com. 10. Institute of Hospital and Health Care Administration, National Yang-Ming University, Taipei, Taiwan. hematcd2@hotmail.com.
Abstract
BACKGROUND: To assess the benefit of postoperative radiotherapy in patients with pT1-2N1M0 oral and oropharyngeal cancer by the quality of neck dissection. METHODS: In the Surveillance, Epidemiology, and End Results database, pT1-2N1M0 oral and oropharyngeal cancer patients treated by primary tumor resection and neck dissection with or without radiotherapy were included between 2004 and 2015. Univariate and multivariate analysis were used to explore the effect of adjuvant radiotherapy on 5-year overall survival (OS) and disease-specific survival (DSS) among different quality of neck dissection. RESULTS: Of the 1765 patients identified, 1108 (62.8%) had oral cancer, 1141 (64.6%) were men, and 1067 (60.5%) underwent adjuvant radiotherapy. After adjusting for confounding factors, postoperative radiotherapy reduced the adjusted hazard ratio (aHR) of 5-year OS to 0.64 (95% confidence interval [CI] 0.49-0.84) in those with < 18 lymph nodes (LNs) removed, but not in those with 19-24 LNs removed (aHR 0.78; 95% CI 0.73-1.13), and in those with ≥ 25 LNs removed (aHR 0.96; 95% CI 0.75-1.24). For 5-year DSS, similar effect was observed. The adjusted hazard ratio was 0.66 (95% confidence interval, 0.45-0.97) in those with < 18 LNs. The protective effect was not seen in those with 18-24 LNs (aHR 1.07; 95% CI 0.59-1.96), and in those with ≥ 25 LNs (aHR 1.12; 95% CI 0.81-1.56). Sensitivity testing also showed a robust protective effect of postoperative radiotherapy in patients with < 18 LNs removed. CONCLUSION: Radiotherapy was associated with improved survival in pT1-2N1M0 oral and oropharyngeal cancer patients without adequate neck dissection.
BACKGROUND: To assess the benefit of postoperative radiotherapy in patients with pT1-2N1M0 oral and oropharyngeal cancer by the quality of neck dissection. METHODS: In the Surveillance, Epidemiology, and End Results database, pT1-2N1M0 oral and oropharyngeal cancerpatients treated by primary tumor resection and neck dissection with or without radiotherapy were included between 2004 and 2015. Univariate and multivariate analysis were used to explore the effect of adjuvant radiotherapy on 5-year overall survival (OS) and disease-specific survival (DSS) among different quality of neck dissection. RESULTS: Of the 1765 patients identified, 1108 (62.8%) had oral cancer, 1141 (64.6%) were men, and 1067 (60.5%) underwent adjuvant radiotherapy. After adjusting for confounding factors, postoperative radiotherapy reduced the adjusted hazard ratio (aHR) of 5-year OS to 0.64 (95% confidence interval [CI] 0.49-0.84) in those with < 18 lymph nodes (LNs) removed, but not in those with 19-24 LNs removed (aHR 0.78; 95% CI 0.73-1.13), and in those with ≥ 25 LNs removed (aHR 0.96; 95% CI 0.75-1.24). For 5-year DSS, similar effect was observed. The adjusted hazard ratio was 0.66 (95% confidence interval, 0.45-0.97) in those with < 18 LNs. The protective effect was not seen in those with 18-24 LNs (aHR 1.07; 95% CI 0.59-1.96), and in those with ≥ 25 LNs (aHR 1.12; 95% CI 0.81-1.56). Sensitivity testing also showed a robust protective effect of postoperative radiotherapy in patients with < 18 LNs removed. CONCLUSION: Radiotherapy was associated with improved survival in pT1-2N1M0 oral and oropharyngeal cancerpatients without adequate neck dissection.
Authors: Vasu Divi; Michelle M Chen; Brian Nussenbaum; Kim F Rhoads; Davud B Sirjani; F Christopher Holsinger; Jennifer L Shah; Wendy Hara Journal: J Clin Oncol Date: 2016-11-10 Impact factor: 44.544
Authors: Michelle M Chen; Jeremy P Harris; Wendy Hara; Davud Sirjani; Vasu Divi Journal: JAMA Otolaryngol Head Neck Surg Date: 2016-12-01 Impact factor: 6.223
Authors: Ardalan Ebrahimi; Jonathan R Clark; Wan Jing Zhang; Michel S Elliott; Kan Gao; Christopher G Milross; Kerwin F Shannon Journal: Head Neck Date: 2010-10-21 Impact factor: 3.147
Authors: Simon N Rogers; James S Brown; Julia A Woolgar; Derek Lowe; Patrick Magennis; Richard J Shaw; David Sutton; Douglas Errington; David Vaughan Journal: Oral Oncol Date: 2008-07-31 Impact factor: 5.337
Authors: Ziv Gil; Diane L Carlson; Jay O Boyle; Dennis H Kraus; Jatin P Shah; Ashok R Shaha; Bhuvanesh Singh; Richard J Wong; Snehal G Patel Journal: Cancer Date: 2009-12-15 Impact factor: 6.860